SCHEMBL147183

SCHEMBL147183

CCNc1ccccc1OCC

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.56
ALDH1A1 P00352 5/20 0.50
KMT2A Q03164 2/20 0.50
CYP2C19 P33261 1/20 0.50
MAPK10 P53779 1/20 0.50
KDM4E B2RXH2 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 1/20 0.47
MCL1 Q07820 1/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
EGFR P00533 1/20 0.46
TSHR P16473 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20508889 0.88 GAA (0.56) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL4535349 0.88 TDP1 (0.51) GAAALDH1A1KMT2ACYP2C19L3MBTL1
SCHEMBL9289413 0.84 GAA (0.53) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL11521594 0.83 MAPK10 (0.62) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL1639715 0.83 GAA (0.59) GAAALDH1A1KMT2ACYP2C19MAPK10
SCHEMBL19001343 0.82 THRB (0.48) GAAKMT2AL3MBTL1LMNAPOLB
SCHEMBL16417513 0.81 THRB (0.47) GAAALDH1A1KMT2ALMNAPOLB
SCHEMBL9461095 0.81 BRD4 (0.59) GAAALDH1A1KMT2AKDM4EL3MBTL1
SCHEMBL23879209 0.81 POLB (0.61) GAAALDH1A1KMT2ACYP2C19KDM4E
SCHEMBL4860536 0.81 GAA (0.50) GAAALDH1A1KMT2ACYP2C19MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130143824-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2013-06-06 US claimed
US-20120058953-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2012-03-08 US claimed
US-20110039324-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2011-02-17 US claimed
US-20090148921-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. (US) 2009-06-11 US claimed
EP-1590666-B1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2008-07-09 EP claimed
EP-1590666-A4 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2006-07-26 EP claimed
EP-1590666-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS Genentech, Inc. (US) 2005-11-02 EP claimed
US-20040171554-A1 Compositions and methods for enhancing apoptosis GENENTECH, INC. 2004-09-02 US claimed
WO-2004072641-A1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH, INC. (US) 2004-08-26 WO claimed
CN-110981743-A Synthetic process method and device of acetaminophen ether raw material medicine 李宾 2020-04-10 CN disclosed
EP-1590666-B1 COMPOSITIONS AND METHODS FOR ENHANCING APOPTOSIS GENENTECH INC (US) 2008-07-09 EP disclosed
US-4060544-A COUPLERS GAF CORPORATION (US) 1977-11-29 US disclosed
US-4039524-A Keto-amido containing phenylazo benzothiazole dyestuffs GAF CORPORATION (US) 1977-08-02 US disclosed
US-3931145-A POLYESTER GAF CORPORATION (US) 1976-01-06 US disclosed